Biomet M2a Magnum Hip Implant Lawsuits
According to court documents, there are now more than 650 Biomet hip lawsuits pending in federal courts, an increase of about 70 from August 2013. In order to increase pretrial efficiency, the Biomet lawsuits have been consolidated in the U.S. District Court for the Northern District of Indiana before Judge Robert L. Miller.
Biomet, the medical device maker with 12% of the domestic hip implant market, was founded in Indiana in 1977. Biomet has annual sales of $2.5 billion and its products are used in over 90 countries. The company’s U.S hip implant sales were $312.9 million in 2010.
The Biomet M2a Magnum implant is a metal-on-metal hip replacement device. Plaintiffs allege that the implant design can cause the hip to shed dangerous amounts of metal debris, leading to serious and debilitating complications. These complications include chronic pain, a popping sound and a grinding sensation in the hip device. The metal debris can also cause premature failure of the device, requiring surgery to remove and replace the implant.
In January 2013, the U.S. Food & Drug Administration (FDA) warned that metal-on-metal hip implants had been associated with higher rates of premature failure compared to those made from other materials. The FDA has proposed new regulations that would subject such implants to more regulatory oversight, and advised recipients with all-metal hips to undergo metal ion blood testing if they experience any symptoms that would indicate their hip may be failing.
If you have had the Biomet M2a Magnum Hip replacement system and are suffering the consequences, it is important that you get expert legal advice from a personal injury lawyer. Our experienced Indiana medical malpractice attorneys offer free consultations to discuss your case. Contact us today to schedule your evaluation.